Reminder: Volcano Corporation Schedules Conference Call, Webcast to Discuss Axsun Transaction

Tuesday, January 6, 2009 General News J E 4
SAN DIEGO, Jan. 5 Volcano Corporation(Nasdaq: VOLC), a leader in the development, manufacturing and sales ofproducts for the diagnosis and treatment of coronary and peripheral arterydisease, will conduct a conference call and webcast Tuesday, January 6, todiscuss its acquisition of Axsun Technologies, Inc., that was announced onDecember 23, 2008.

The teleconference call and webcast will begin at 1 p.m., Eastern StandardTime (10 a.m., Pacific Standard Time), and can be accessed by calling(719) 325-4842, passcode 8476994, or via the company's website at Please dial in or access the webcast 10-15 minutesprior to the beginning of the call. A replay of the conference call will beavailable through January 13, at (719) 457-0820, passcode 8476994, and via thecompany's website.

Volcano Corporation

Volcano Corporation (NASDAQ: VOLC) offers a broad suite of devicesdesigned to facilitate endovascular procedures, enhance the diagnosis ofvascular and structural heart disease and guide optimal therapies. Thecompany's intravascular ultrasound (IVUS) product line includes ultrasoundconsoles that can be integrated directly into virtually any modern cath lab.Volcano IVUS offers unique features, including both single-use phased arrayand rotational IVUS imaging catheters, and advanced functionality options,such as VH(R) IVUS tissue characterization and ChromaFlo(R). Volcano alsoprovides functional measurement (FM) consoles and single-use pressure and flowguide wires and is developing a line of ultra-high resolution OpticalCoherence Tomography (OCT) systems and catheters. Currently, more than 3,700Volcano IVUS and FM systems are installed worldwide, with approximately halfof its revenues coming from outside the United Sates. For more information,visit the company's website at

SOURCE Volcano Corporation


You May Also Like

View All

Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
User Avatar
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions
Cambrex Presentation at The JPMorgan Healthcare Co...
Medical Simulation Corporation to Introduce Ventil...